Judesio diagnostikos klinika, MB - financials and debts

Company age: 6 y. 8 mo.

Update

Judesio diagnostikos klinika - Company finances

EUR
2020
From: 2020-01-21
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 6,528 13,664 22,687 34,323 32,518 37,189
Profit before tax -2,201 2,653 219 2,587 24,466 428
Net profit -2,201 2,520 208 2,458 22,679 213
Equity -2,200 319 527 2,985 3,164 3,378
Liabilities - - 2,553 4,517 5,863 6,259
Non-current assets 0 0 0 0 0 0
Current assets 1,765 1,569 3,080 7,502 9,027 9,637
Total assets 1,765 1,569 3,080 7,502 9,027 9,637
Taxes paid
STI taxes - - - 11 290 1,983
Financial indicators
Revenue change y/y - +109.3% +66.0% +51.3% -5.3% +14.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -124.7% 160.6% 6.8% 32.8% 251.2% 2.2%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 790.0% 39.5% 82.3% 716.8% 6.3%
Profit margin Net profit margin. Shows the overall profitability of the company. -33.7% 18.4% 0.9% 7.2% 69.7% 0.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -33.7% 19.4% 1.0% 7.5% 75.2% 1.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - 4.8 1.5 1.9 1.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - - - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Judesio diagnostikos klinika - Social security debts

The amount of overdue SODRA debt for the company Judesio diagnostikos klinika as of the last working day is: 161 €

From To Debt, €
2026-09-05 2026-09-16 160.93
2026-09-01 2026-09-02 160.93
2026-08-26 2026-08-31 80.45
2026-08-23 2026-08-23 80.45
2026-08-19 2026-08-19 80.45
2026-08-16 2026-08-17 80.45
2026-08-01 2026-08-14 80.45
2026-07-01 2026-07-31 238.89
2026-06-02 2026-06-30 158.41
2026-05-03 2026-06-01 77.93
2026-04-01 2026-04-30 241.41
2026-03-03 2026-03-31 160.93
2026-02-03 2026-03-02 80.45
2025-12-02 2025-12-31 507.91
2025-11-01 2025-12-01 435.46
2025-10-01 2025-10-31 363.01
2025-09-18 2025-09-30 290.56
2025-09-02 2025-09-17 467.31
2025-08-01 2025-09-01 394.86
2025-07-01 2025-07-31 322.41
2025-06-03 2025-06-30 249.96
2025-05-04 2025-06-02 177.51
2025-04-26 2025-04-30 105.11
2025-04-14 2025-04-25 28.42
2023-07-19 2023-07-31 636.23
2023-01-03 2023-01-31 101.90
2022-11-03 2023-01-02 50.95
2022-10-03 2022-10-31 50.95
2022-09-01 2022-09-30 50.95
2022-08-02 2022-08-31 101.90
2022-05-03 2022-08-01 50.95
2022-02-01 2022-04-30 50.95
2022-01-26 2022-01-31 108.05
2022-01-03 2022-01-25 152.86
2021-12-16 2021-12-31 108.05
2021-11-04 2021-12-15 44.81
2021-10-15 2021-10-31 108.05
2021-10-01 2021-10-14 44.81
2021-09-10 2021-09-30 108.05

Judesio diagnostikos klinika - VMI tax arrears

From To Overdue, €
2026-07-28 2026-08-13 0.1
2026-07-19 2026-07-27 55.22
2026-07-01 2026-07-18 55.05
2026-06-28 2026-06-30 55.0
2026-01-29 2026-01-29 2.07
2025-08-01 2026-01-28 0.07
2025-07-31 2025-07-31 0.05

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Judesio diagnostikos klinika, MB (company code 305434473) is a Lithuanian small partnership engaged in physiotherapy activities. In 2025, the latest financial year, the company generated revenue of €37.2K, up 14.4% year on year and 8.3% over two years. Net profit was €213, compared with €22.7K in 2024 and €2.5K in 2023, showing a sharp decline in profitability after a strong 2024 result. The 2025 profit margin was 0.6%, while 2024 margin reached 69.7% and 2023 margin was 7.2%. Balance sheet size remained modest, with total assets of €9.6K, equity of €3.4K and liabilities of €6.3K at the end of 2025. The equity ratio was 35.0%, debt-to-equity 1.85, asset turnover 3.86x, ROE 6.3% and ROA 2.2%. Overall, the company showed revenue growth in 2025, but earnings weakened materially compared with the previous year.